The Development of an Antimicrobial Contact Lens – From the Laboratory to the Clinic

Author(s): Mark D.P. Willcox*, R. Chen, P. Kalaiselvan, M. Yasir, R. Rasul, N. Kumar, D. Dutta.

Journal Name: Current Protein & Peptide Science

Volume 21 , Issue 4 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Contact lens wear is generally safe and provides excellent vision. However, contact lens wear is often associated with the risk of developing ocular surface infection and inflammation, and in severe cases, the infection can result in loss of vision. Antimicrobial peptide-coated contact lenses have been made to help reduce the incidence of infection and inflammation. This paper reviews the research progress from conception, through the laboratory and preclinical tests to the latest information on clinical testing of an antimicrobial contact lens. We provide insights into the pathways followed and pitfalls that have been encountered. The journey has not always been linear or smooth, but has resulted in some of the first published clinical testing of antimicrobial peptide-coated contact lenses in humans. We hope this may help lead to the development and commercialisation of antimicrobial contact lenses in the future.

Keywords: Contact lens, keratitis, antimicrobial peptide, clinical trial, melamine, MeL4.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 4
Year: 2020
Page: [357 - 368]
Pages: 12
DOI: 10.2174/1389203720666190820152508
Price: $65

Article Metrics

PDF: 9